Lamotrigine ER
- Product NDC
- 72189-560
- Requested package NDC
- 72189-560-30
- 11-digit product format
- 721890560
- Labeler code
- 72189
- Product ID
- 72189-560_1b42a7cf-86d9-e506-e063-6394a90a3c9b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamotrigine ER
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Direct_rx
- Application
- ANDA213949
- Marketing category
- ANDA
- Marketing start
- 2024-06-19
- Substance
- LAMOTRIGINE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE], Dihydrofolate Reductase Inhibitors [MoA], Mood Stabilizer [EPC], Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A213949-001 | LAMOTRIGINE | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | |
| A213949-002 | LAMOTRIGINE | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | |
| A213949-003 | LAMOTRIGINE | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | |
| A213949-004 | LAMOTRIGINE | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | |
| A213949-005 | LAMOTRIGINE | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | |
| A213949-006 | LAMOTRIGINE | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A213949-001 | AB |
| A213949-002 | AB |
| A213949-003 | AB |
| A213949-004 | AB |
| A213949-005 | AB |
| A213949-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A213949-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A213949-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A213949-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A213949-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A213949-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A213949-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A213949-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A213949-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A213949-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A213949-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A213949-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A213949-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-005 | LAMOTRIGINE | 250MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-006 | LAMOTRIGINE | 300MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-001 | LAMOTRIGINE | 25MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-002 | LAMOTRIGINE | 50MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-003 | LAMOTRIGINE | 100MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-004 | LAMOTRIGINE | 200MG | TABLET, EXTENDED RELEASE / ORAL | AB | 2021-12-08 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A213949-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A213949-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A213949-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A213949-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A213949-005 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A213949-006 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A213949-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A213949-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A213949-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A213949-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A213949-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A213949-006 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A213949-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A213949-006 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-005 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A213949-006 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-005 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A213949-006 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A213949-004 | AB | 1 | b8a1b40f171c… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lamotrigine ER
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LAMOTRIGINE | 200 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| U3H27498KS | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 900156 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1b42a7cf-86d8-e506-e063-6394a90a3c9b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 14a9502b-3d70-0496-a7e1-b16edaa005b8 | Product name | 5 | 20250423 |
| 16d731ed-ff3e-e9a1-3e3e-1ef6b6be40a0 | Product name | 7 | 20250401 |
| e29d8e8b-4bc8-ebaf-f18e-e35287b19d6a | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72189-560-30 | Lamotrigine ER | 30 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 30 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72189-560-30 | EA - Each | 72189-560 | b7db1d29-a244-4fe4-a2c2-b6c1a515239d | 1 | 2024-07-12 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| lamotrigine | LAMOTRIGINE EXTENDED-RELEASE | REMEDYREPACK INC. | 65748114-c59c-4ebb-977e-d4aab5764dd3 | 2026-04-27 | Boxed warning, Warnings, Adverse reactions | 213949 ANDA213949 |
| lamotrigine | LAMOTRIGINE EXTENDED-RELEASE | Camber Pharmaceuticals Inc | e45bd69f-3580-ff15-e053-2a95a90a4615 | 2026-02-02 | Boxed warning, Warnings, Adverse reactions | 213949 ANDA213949 |
| lamotrigine | LAMOTRIGINE EXTENDED-RELEASE | Yiling Pharmaceutical, Inc. | f7de11a5-5357-4753-b1ac-b15123b50028 | 2025-12-29 | Boxed warning, Warnings, Adverse reactions | 213949 ANDA213949 |
| Lamotrigine ER | LAMOTRIGINE ER | Direct_rx | 1b42a7cf-86d8-e506-e063-6394a90a3c9b | 2024-06-19 | Boxed warning, Warnings, Adverse reactions | 213949 ANDA213949 72189-560-30 72189-560 72189056030 |
| lamotrigine | LAMOTRIGINE EXTENDED-RELEASE | Proficient Rx LP | 39efe933-bfed-4a6a-b270-0883871c5186 | 2023-10-01 | Boxed warning, Warnings, Adverse reactions | 213949 ANDA213949 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 900156 | lamoTRIgine 200 MG 24HR Extended Release Oral Tablet | PSN | 1b42a7cf-86d8-e506-e063-6394a90a3c9b | 1 |
| 900156 | 24 HR lamotrigine 200 MG Extended Release Oral Tablet | SCD | 1b42a7cf-86d8-e506-e063-6394a90a3c9b | 1 |
| 900156 | lamotrigine 200 MG 24 HR Extended Release Oral Tablet | SY | 1b42a7cf-86d8-e506-e063-6394a90a3c9b | 1 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 72189-560-30 | 72189056030 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (72189-560-30) | 2024-06-19 | No | No | Current |